Gynecomastia Procedures Market Report 2026

The gynecomastia procedures market size has grown strongly in recent years. It will grow from $1.12 billion in 2025 to $1.21 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing awareness of gynecomastia conditions, growth in cosmetic surgery acceptance, expansion of private cosmetic clinics, rising availability of advanced surgical tools, improved hormonal disorder diagnosis.

The gynecomastia procedures market size is expected to see strong growth in the next few years. It will grow to $1.62 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing demand for outpatient cosmetic procedures, rising use of non-invasive energy-based devices, expansion of aesthetic medicine investments, growing focus on personalized treatment planning, increasing adoption of ultrasound-assisted procedures. Major trends in the forecast period include increasing preference for minimally invasive procedures, rising demand for cosmetic male health treatments, growing adoption of advanced liposuction techniques, expansion of non-surgical treatment options, enhanced focus on patient-centric outcomes.

The increasing prevalence of obesity is expected to drive the growth of the gynecomastia procedures market in the coming years. Obesity is a medical condition defined by excessive body fat accumulation, typically measured by a body mass index (BMI) of 30 or higher, which can lead to multiple health complications. The rise in obesity is largely due to sedentary lifestyles, where prolonged physical inactivity contributes to weight gain and poor metabolic health. Gynecomastia procedures address the enlargement of male breasts, a condition often worsened by obesity, as excess fat tissue in the chest can mimic or exacerbate gynecomastia, making surgical intervention a valuable solution. For instance, in March 2023, according to the World Heart Foundation, a Switzerland-based non-governmental organization, approximately 2.3 billion adults and children worldwide are obese or overweight, and with current trends, this number is projected to reach 2.7 billion by 2025. Therefore, the rising prevalence of obesity is driving the growth of the gynecomastia procedures market.

Major companies in the gynecomastia procedures market are focusing on advanced innovations such as non-invasive treatments to minimize surgical risks, improve patient outcomes, and address the demand for safer and more effective therapies. Non-invasive treatments refer to approaches that avoid surgery, using oral medications or external therapies to manage conditions like gynecomastia without incisions or anesthesia. For instance, in June 2024, BioZen Limited, a UK-based biotechnology company, launched a novel daily pill regimen aimed at treating gynecomastia. This proprietary dual-therapy formulation combines a low dose of tamoxifen (TAM) with indole-3-carbinol (I3C), a naturally occurring compound from cruciferous vegetables, administered as a convenient once-daily oral medication. Preclinical studies from BioZen indicate that this dual approach can effectively reverse the hormonal imbalances driving gynecomastia, offering a potentially safe, effective, and scalable alternative to surgical procedures.

In July 2024, Optical Express, a UK-based healthcare company, acquired Harley Medical Group for an undisclosed amount. Through this acquisition, Optical Express aims to expand its multidisciplinary healthcare offerings by integrating cosmetic and dermatological services into its existing eye care operations across a wider network in the UK and Europe. Harley Medical Group is a UK-based cosmetic surgery provider specializing in procedures including gynecomastia surgery.

Major companies operating in the gynecomastia procedures market are Spire Healthcare Group plc, InMode Ltd., Lumenis Ltd., Cynosure LLC, Max Healthcare Institute Limited, Alma Lasers Ltd., Pristyn Care Private Limited, Cutera Inc., Solta Medical Inc., Erchonia Corporation, MicroAire Surgical Instruments LLC, Allure Medspa, Florida Plastic Surgery Group P.A., The Aesthetica, Austin Gynecomastia Center, Apyx Medical Corporation.

North America was the largest region in the gynecomastia procedures market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gynecomastia procedures market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gynecomastia procedures market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the gynecomastia procedures market by increasing costs of imported surgical instruments, ultrasound devices, liposuction systems, medical consumables, and post-operative care products. Cosmetic surgery centers in North America and Europe are most affected due to reliance on imported aesthetic equipment, while Asia-Pacific faces pricing pressure on device manufacturing and exports. These tariffs are raising procedural costs and influencing pricing strategies. However, they are also encouraging local production of aesthetic devices, regional supplier development, and increased adoption of cost-efficient treatment technologies.

The gynecomastia procedures market research report is one of a series of new reports that provides gynecomastia procedures market statistics, including gynecomastia procedures industry global market size, regional shares, competitors with a gynecomastia procedures market share, detailed gynecomastia procedures market segments, market trends and opportunities, and any further data you may need to thrive in the gynecomastia procedures industry. This gynecomastia procedures market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Gynecomastia procedures are medical treatments aimed at reducing the enlargement of male breast tissue, often resulting from hormonal imbalances. The purpose of these procedures is to restore a more masculine chest appearance, relieve physical discomfort, and enhance psychological well-being for affected individuals.

The primary forms of gynecomastia procedures include liposuction, mastectomy, thyroid hormone therapy, medications, and ultrasound. Liposuction is a cosmetic surgical technique that removes excess fat from targeted areas of the body using a suction method to reshape and contour the chest. The key age groups undergoing these procedures are adolescents, adults, and the elderly, while the main end-users comprise hospitals, cosmetic surgery centers, and related healthcare facilities.

The gynecomastia procedure market consists of revenues earned by entities by providing services such as laser therapy, minimally invasive procedures, post-operative care and follow-up services, and consultation and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.